General

https://www.einpresswire.com/article/919178783/abl-diagnostics-announces-renewal-of-u-s-patent-us-8-859-198-b2-for-hepatitis-b-genotyping-and-antiviral-resistance

https://www.businesswire.com/news/home/20260611674142/en/ABL-Diagnostics-and-CDL-Pharma-Secure-a-Multi-year-International-Contract-of-up-to-%E2%82%AC2.7-Million-Through-2031

https://www.einpresswire.com/article/918127065/abl-diagnostics-showcases-scientific-progress-at-emhh-2026-supporting-strategic-positioning-in-molecular-technologies

https://www.einpresswire.com/article/918135269/abl-diagnostics-advances-platform-agnostic-ngs-strategy-through-deepchek-verification-on-element-biosciences-aviti

https://www.einpresswire.com/article/917550254/abl-diagnostics-deepens-laboratory-footprint-with-launch-of-hybridchek-for-hiv-and-tuberculosis-whole-genome-sequencing

https://www.businesswire.com/news/home/20260601791272/en/ABL-Diagnostics-Presents-Its-Financial-Roadmap-and-Growth-Outlook-for-2026

https://www.einpresswire.com/article/916012021/abl-diagnostics-broadens-ultragene-syndromic-qpcr-portfolio

https://www.einpresswire.com/article/915738686/ultragene-ebola-multiplex-qpcr-for-outbreak-preparedness

https://www.einpresswire.com/article/914346495/abl-diagnostics-advances-ngs-for-cmv-resistance-monitoring-at-seimc-2026

https://www.einpresswire.com/article/914324401/abl-diagnostics-et-le-chru-nancy-premier-bilan-positif-pour-le-projet-predavir-apr-s-6-mois